Intelligent Investor

Allkem Limited (ASX: AKE) - Announcements

DELISTED - Current share price for AKE : $9.830

ASX company news and announcements for Allkem Limited (AKE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Allkem Limited (AKE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Allkem Limited (AKE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Allkem Limited (AKE)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Appendix 4G 25 Aug 2022 8:08AM $13.880 $9.830 $9.830 fallen by 29.18%
- FY22 Results Presentation 25 Aug 2022 8:07AM $13.880 $9.830 $9.830 fallen by 29.18%
- Allkem Delivers Record Full Year Results 25 Aug 2022 8:06AM $13.880 $9.830 $9.830 fallen by 29.18%
- Annual Report to shareholders and Appendix 4E 25 Aug 2022 8:06AM $13.880 $9.830 $9.830 fallen by 29.18%
- Mt Cattlin Resource, Reserve and Operations Update 25 Aug 2022 8:00AM $13.880 $9.830 $9.830 fallen by 29.18%
- Allkem to acquire lithium tenement in exchange for Borax 15 Aug 2022 9:23AM $12.400 $9.830 $9.830 fallen by 20.73%
- FY22 Full Year Results Briefing 11 Aug 2022 1:29PM $12.380 $9.830 $9.830 fallen by 20.60%
- June 2022 Quarterly Activities Report 20 Jul 2022 8:37AM $9.800 $9.830 $9.830 risen by 0.31%
- June 2022 Quarter Results Briefing 13 Jul 2022 5:01PM $9.640 $9.830 $9.830 risen by 1.97%
- Notification of cessation of securities - AKE 13 Jul 2022 4:53PM $9.640 $9.830 $9.830 risen by 1.97%
- Ceasing to be a substantial holder 11 Jul 2022 4:24PM $10.000 $9.830 $9.830 fallen by 1.70%
- Notification of cessation of securities - AKE 9 Jun 2022 2:42PM $11.300 $9.830 $9.830 fallen by 13.01%
- Notification regarding unquoted securities - AKE 8 Jun 2022 12:15PM $11.660 $9.830 $9.830 fallen by 15.69%
- Notification regarding unquoted securities - AKE 6 Jun 2022 11:56AM $11.670 $9.830 $9.830 fallen by 15.77%
- Pricing and operational update 6 Jun 2022 8:31AM $11.870 $9.830 $9.830 fallen by 17.19%
- Notification of cessation of securities - AKE 14 Apr 2022 2:33PM $13.480 $9.830 $9.830 fallen by 27.08%
- March Quarter Activities Report (Updated) 14 Apr 2022 9:26AM $13.260 $9.830 $9.830 fallen by 25.87%
- March Quarter Activities Report 14 Apr 2022 8:33AM $13.260 $9.830 $9.830 fallen by 25.87%
- Strategy Presentation - April 2022 5 Apr 2022 8:26AM $13.310 $9.830 $9.830 fallen by 26.15%
- Sal de Vida capacity increased to 45ktpa in 2 stages 4 Apr 2022 6:55PM $13.310 $9.830 $9.830 fallen by 26.15%
- Olaroz interim resource update and Stage 2 economics 4 Apr 2022 6:48PM $13.310 $9.830 $9.830 fallen by 26.15%
- Lithium carbonate and spodumene concentrate pricing update 1 Apr 2022 9:48AM $11.430 $9.830 $9.830 fallen by 14%
- Application for quotation of securities - AKE 31 Mar 2022 2:02PM $11.460 $9.830 $9.830 fallen by 14.22%
- Investor Strategy Day Briefing 16 Mar 2022 4:20PM $9.490 $9.830 $9.830 risen by 3.58%
- Allkem FY22 Half Year Results 28 Feb 2022 8:18AM $9.100 $9.830 $9.830 risen by 8.02%

151 - 175 of 186 results

Page 7 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.